Cargando…
Glucocappasalin Induces G2/M-Phase Arrest, Apoptosis, and Autophagy Pathways by Targeting CDK1 and PLK1 in Cervical Carcinoma Cells
Glucocappasalin (GCP), a natural product derived from the seeds of Descurainia sophia (L.) Webb. ex Prantl, exhibits potential antitumor activity in HeLa cervical carcinoma cells. In this study, we investigated the anti-cervical cancer property of GCP through the induction of cell cycle arrest, apop...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172611/ https://www.ncbi.nlm.nih.gov/pubmed/34093198 http://dx.doi.org/10.3389/fphar.2021.671138 |
_version_ | 1783702566895353856 |
---|---|
author | Xu, Guangya Yan, Xueling Hu, Zhongjia Zheng, Lulu Ding, Ke Zhang, Yamei Qing, Yi Liu, Tao Cheng, Lijia Shi, Zheng |
author_facet | Xu, Guangya Yan, Xueling Hu, Zhongjia Zheng, Lulu Ding, Ke Zhang, Yamei Qing, Yi Liu, Tao Cheng, Lijia Shi, Zheng |
author_sort | Xu, Guangya |
collection | PubMed |
description | Glucocappasalin (GCP), a natural product derived from the seeds of Descurainia sophia (L.) Webb. ex Prantl, exhibits potential antitumor activity in HeLa cervical carcinoma cells. In this study, we investigated the anti-cervical cancer property of GCP through the induction of cell cycle arrest, apoptosis, and autophagy in vitro and in vivo, and elucidated the underlying molecular mechanisms. We demonstrated that treatment with GCP inhibited the growth of HeLa, Siha, and Ca Ski cell lines in a dose-dependent manner, with HeLa cells displaying particular sensitivity to the GCP treatment. Subsequently, the expression of cyclin-dependent kinase 1 (CDK1) and polo like kinase 1 (PLK1) were evaluated in HeLa cells using the CDK1 kinase assay kit, the fluorescence polarization assay, real-time quantitative PCR, and western blotting. Our results demonstrate that GCP could be employed to attenuate the expression of CDK1 and PLK1 in a dose- and time-dependent manner. The complementary results obtained by flow cytometry and western blotting allowed us to postulate that GCP may exhibit its antitumor effects by inducing G2/M cell cycle arrest. Moreover, HeLa cells treated with GCP exhibited a loss in mitochondrial membrane potential, together with the activation of caspases 3 and 9, and poly ADP-ribose polymerase (PARP). Additionally, we found that GCP could increase the formation of acidic vesicular organelles (AVOs), as well as the levels of Beclin1, LC3-II, p62, and Atg5 proteins in HeLa cells. Further studies indicated that GCP triggered autophagy via the suppression of the PI3K/AKT/mTOR signaling pathways. The autophagy inhibitor 3-methyladenine (3-MA) was used to determine whether autophagy affects the apoptosis induced by GCP. Interestingly, the inhibition of autophagy attenuated apoptosis. In vivo anti-tumor experiments indicated that GCP (60 mg/kg, i.p.) markedly reduced the growth of HeLa xenografts in nude mice without apparent toxicity. Taken together, we demonstrate that GCP induces cell cycle G2/M-phase arrest, apoptosis, and autophagy by acting on the PI3K/AKT/mTOR signaling pathways in cervical carcinoma cells. Thus, GCP may represent a promising agent in the eradication of cervical cancer. |
format | Online Article Text |
id | pubmed-8172611 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81726112021-06-04 Glucocappasalin Induces G2/M-Phase Arrest, Apoptosis, and Autophagy Pathways by Targeting CDK1 and PLK1 in Cervical Carcinoma Cells Xu, Guangya Yan, Xueling Hu, Zhongjia Zheng, Lulu Ding, Ke Zhang, Yamei Qing, Yi Liu, Tao Cheng, Lijia Shi, Zheng Front Pharmacol Pharmacology Glucocappasalin (GCP), a natural product derived from the seeds of Descurainia sophia (L.) Webb. ex Prantl, exhibits potential antitumor activity in HeLa cervical carcinoma cells. In this study, we investigated the anti-cervical cancer property of GCP through the induction of cell cycle arrest, apoptosis, and autophagy in vitro and in vivo, and elucidated the underlying molecular mechanisms. We demonstrated that treatment with GCP inhibited the growth of HeLa, Siha, and Ca Ski cell lines in a dose-dependent manner, with HeLa cells displaying particular sensitivity to the GCP treatment. Subsequently, the expression of cyclin-dependent kinase 1 (CDK1) and polo like kinase 1 (PLK1) were evaluated in HeLa cells using the CDK1 kinase assay kit, the fluorescence polarization assay, real-time quantitative PCR, and western blotting. Our results demonstrate that GCP could be employed to attenuate the expression of CDK1 and PLK1 in a dose- and time-dependent manner. The complementary results obtained by flow cytometry and western blotting allowed us to postulate that GCP may exhibit its antitumor effects by inducing G2/M cell cycle arrest. Moreover, HeLa cells treated with GCP exhibited a loss in mitochondrial membrane potential, together with the activation of caspases 3 and 9, and poly ADP-ribose polymerase (PARP). Additionally, we found that GCP could increase the formation of acidic vesicular organelles (AVOs), as well as the levels of Beclin1, LC3-II, p62, and Atg5 proteins in HeLa cells. Further studies indicated that GCP triggered autophagy via the suppression of the PI3K/AKT/mTOR signaling pathways. The autophagy inhibitor 3-methyladenine (3-MA) was used to determine whether autophagy affects the apoptosis induced by GCP. Interestingly, the inhibition of autophagy attenuated apoptosis. In vivo anti-tumor experiments indicated that GCP (60 mg/kg, i.p.) markedly reduced the growth of HeLa xenografts in nude mice without apparent toxicity. Taken together, we demonstrate that GCP induces cell cycle G2/M-phase arrest, apoptosis, and autophagy by acting on the PI3K/AKT/mTOR signaling pathways in cervical carcinoma cells. Thus, GCP may represent a promising agent in the eradication of cervical cancer. Frontiers Media S.A. 2021-05-20 /pmc/articles/PMC8172611/ /pubmed/34093198 http://dx.doi.org/10.3389/fphar.2021.671138 Text en Copyright © 2021 Xu, Yan, Hu, Zheng, Ding, Zhang, Qing, Liu, Cheng and Shi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Xu, Guangya Yan, Xueling Hu, Zhongjia Zheng, Lulu Ding, Ke Zhang, Yamei Qing, Yi Liu, Tao Cheng, Lijia Shi, Zheng Glucocappasalin Induces G2/M-Phase Arrest, Apoptosis, and Autophagy Pathways by Targeting CDK1 and PLK1 in Cervical Carcinoma Cells |
title | Glucocappasalin Induces G2/M-Phase Arrest, Apoptosis, and Autophagy Pathways by Targeting CDK1 and PLK1 in Cervical Carcinoma Cells |
title_full | Glucocappasalin Induces G2/M-Phase Arrest, Apoptosis, and Autophagy Pathways by Targeting CDK1 and PLK1 in Cervical Carcinoma Cells |
title_fullStr | Glucocappasalin Induces G2/M-Phase Arrest, Apoptosis, and Autophagy Pathways by Targeting CDK1 and PLK1 in Cervical Carcinoma Cells |
title_full_unstemmed | Glucocappasalin Induces G2/M-Phase Arrest, Apoptosis, and Autophagy Pathways by Targeting CDK1 and PLK1 in Cervical Carcinoma Cells |
title_short | Glucocappasalin Induces G2/M-Phase Arrest, Apoptosis, and Autophagy Pathways by Targeting CDK1 and PLK1 in Cervical Carcinoma Cells |
title_sort | glucocappasalin induces g2/m-phase arrest, apoptosis, and autophagy pathways by targeting cdk1 and plk1 in cervical carcinoma cells |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172611/ https://www.ncbi.nlm.nih.gov/pubmed/34093198 http://dx.doi.org/10.3389/fphar.2021.671138 |
work_keys_str_mv | AT xuguangya glucocappasalininducesg2mphasearrestapoptosisandautophagypathwaysbytargetingcdk1andplk1incervicalcarcinomacells AT yanxueling glucocappasalininducesg2mphasearrestapoptosisandautophagypathwaysbytargetingcdk1andplk1incervicalcarcinomacells AT huzhongjia glucocappasalininducesg2mphasearrestapoptosisandautophagypathwaysbytargetingcdk1andplk1incervicalcarcinomacells AT zhenglulu glucocappasalininducesg2mphasearrestapoptosisandautophagypathwaysbytargetingcdk1andplk1incervicalcarcinomacells AT dingke glucocappasalininducesg2mphasearrestapoptosisandautophagypathwaysbytargetingcdk1andplk1incervicalcarcinomacells AT zhangyamei glucocappasalininducesg2mphasearrestapoptosisandautophagypathwaysbytargetingcdk1andplk1incervicalcarcinomacells AT qingyi glucocappasalininducesg2mphasearrestapoptosisandautophagypathwaysbytargetingcdk1andplk1incervicalcarcinomacells AT liutao glucocappasalininducesg2mphasearrestapoptosisandautophagypathwaysbytargetingcdk1andplk1incervicalcarcinomacells AT chenglijia glucocappasalininducesg2mphasearrestapoptosisandautophagypathwaysbytargetingcdk1andplk1incervicalcarcinomacells AT shizheng glucocappasalininducesg2mphasearrestapoptosisandautophagypathwaysbytargetingcdk1andplk1incervicalcarcinomacells |